Home > News > OctoPlus secures Euro 18.25 million in second financing round
January 20th, 2005
OctoPlus secures Euro 18.25 million in second financing round
Abstract:
OctoPlus, a drug delivery and development company announced today that it has raised Euro 18.25 million (US$23.85 million) in a second financing round from an international group of investors. The investment was led by Life Sciences Partners II B.V. and S.R. One, Ltd. Other investors participating in this round of financing are Innoven Partenaires, Fortis Private Equity and SurModics, Inc. Fortis Bank acted as OctoPlus' exclusive financial advisor and placement agent in the financing.
Source:
OctoPlus
Bookmark:
Investments/IPO's/Splits
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013
Nanostart-holding New Asia Investments invests in breakthrough water projects May 13th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Announcements
Artificial Forest for Solar Water-Splitting: Berkeley Lab Researchers Report First Fully Integrated Artificial Photosynthesis Nanosystem May 17th, 2013
Moth-Inspired Nanostructures Take the Color Out of Thin Films May 17th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013